- Home
- GOODO vs SRPT Comparison
GOODO vs SRPT Comparison
Compare GOODO & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GOODO
Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Current Price
Current Price
Company Overview
Basic Information| Metric | GOODO | SRPT |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | 72 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.3B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | GOODO | SRPT |
|---|---|---|
| Price | $20.65 | $23.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 29 |
| Target Price | N/A | ★ $26.23 |
| AVG Volume (30 Days) | N/A | ★ 2.8M |
| Earning Date | N/A | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,413,715,000.00 |
| Revenue This Year | N/A | $13.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.15 |
| 52 Week Low | N/A | $10.42 |
| 52 Week High | N/A | $129.84 |
Technical Indicators
Market Signals| Indicator | GOODO | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 63.20 |
| Support Level | $20.62 | $20.86 |
| Resistance Level | $21.29 | $22.00 |
| Average True Range (ATR) | 0.31 | 1.01 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 47.16 | 83.59 |
Price Performance
Historical ComparisonAbout GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.